Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05650_nanopub.RA8oo_1BCeOLDHSKS_h5PxsylWDSZvoY9eSZf0lWuZ4AU#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05650 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05650 label "OT-551 [drugbank:DB05650]" assertion.
- drugbank:DB05650 seeAlso DB05650 assertion.
- drugbank:DB05650 description "OT-551 is a novel small molecule that is topically dosed in an eye drop and has the unique ability to penetrate cell membranes and reach both the front and the back of the eye. It is intended to treat Age-related macular Degeneration (AMD), and preclinical research results indicate additional uses for OT-551, including treatment of early stage and advanced dry age-related macular degeneration (AMD) by protecting against retina photoreceptor cell death and inhibiting angiogenesis, the growth of small blood vessels leading to the wet-form of AMD. A leading cause of vision loss, AMD affects approximately 10 million Americans." assertion.
- drugbank:DB05650 identifier "drugbank:DB05650" assertion.
- drugbank:DB05650 title "OT-551" assertion.
- drugbank:DB05650 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05650 drugbank_vocabulary:drugbank-id "DB05650" assertion.
- drugbank:DB05650 bio2rdf_vocabulary:x-identifiers.org DB05650 assertion.
- drugbank:DB05650 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05650" assertion.
- drugbank:DB05650 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05650 bio2rdf_vocabulary:identifier "DB05650" assertion.